Session Type
Meeting
Search Results for immune checkpoint inhibitors
Abstract Number: 442
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: We are presenting a case of a 71-year-old male patient with a history of hypertension, non-insulin dependent type 2 diabetes mellitus (DM) well controlled on metformin, and non-invasive high grade urothelial bladder cancer diagnosed in 2014 treated with transurethral resection of the prostate and intravesicular mitomycin. In 2016, his bladder cancer has progressed […]
Abstract Number: 484
SHM Converge 2021
Case Presentation: A 78 year old man with recurrent metastatic adenosquamous lung carcinoma (recently initiated pembrolizumab), CAD s/p CABG, HTN, DM2, and HLD, presented with 2 weeks of fatigue, myalgias, anorexia, and weakness acutely worsening in the prior 2 days. He had no fever, chills, chest pain, dyspnea, orthopnea, palpitations, or lower extremity edema. ED […]
Abstract Number: 548
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: 90-year-old female presented with generalized weakness, nausea, vomiting, and diarrhea of 3 days duration. She also reported anorexia but denied any fever, chills, abdominal pain, chest pain, shortness of breath and cough. Vital signs were unremarkable. Physical exam was remarkable for dry oral mucous membranes, the presence of bilateral nephrostomy tubes and costovertebral […]
Abstract Number: 612
SHM Converge 2021
Case Presentation: The patient is a 38-year-old Caucasian female who was diagnosed with Stage IIIb malignant melanoma. The excision of the left scapular lesion and axillary dissection was performed. Baseline 18F-FDG PET scan showed no evidence of metastatic disease. After the 5th cycle of Nivolumab treatment, the patient developed 38 ºC fever and grade 2 […]
Abstract Number: 636
SHM Converge 2023
Case Presentation: This case describes a 63-year-old male who was recently diagnosed with renal cell carcinoma with metastasis to the lungs confirmed with a biopsy showing diffuse PAX-8 positivity on an immunohistochemical staining panel favoring renal origin. He was started on Nivolumab/Ipilimumab however was hospitalized in the intensive care unit for septic shock due to […]
Abstract Number: 786
SHM Converge 2023
Case Presentation: A 76-year-old female with a history of hypertension, BMI 48 kg/m2, hypothyroidism, and metastatic melanoma presented with a 2-week history of progressive myalgia, weakness, and dyspnea 3 weeks after the first infusion of nivolumab and relatlimab.In July 2019, she was diagnosed with stage IIB (cT4a, cN0, cM0) melanoma of the left leg (4.2 […]
Abstract Number: 819
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 77 year old man with stage IIIC mucosal melanoma, hypothyroidism, HTN and COPD presents from an outside hospital with two months of rapidly progressive altered mental status. He was diagnosed with melanoma of the oral palate, left parotid gland and neck one year ago, and underwent two cycles of ipilimumab (ipi) and […]
Abstract Number: 837
SHM Converge 2023
Case Presentation: A 69-year-old male with a past medical history of urothelial carcinoma status post left nephrectomy began immunotherapy and was started on Atezolizumab. He developed bilateral lower extremity weakness that began following his first dose. After 3 doses, in 02/2022, his lower extremity weakness worsened to the point where he could not walk. A […]
Abstract Number: 889
SHM Converge 2024
Case Presentation: A 55-year-old female with a history of renal cell carcinoma treated with left-nephrectomy and Pembrolizumab-immunotherapy presents with complaints of weakness, orthostatic hypotension, nausea, and vomiting with food aversion. She had been admitted with similar complaints 9 times since her left nephrectomy, each time having received full workups including extensive sub-specialty evaluations including cardiology, […]